Researchers explore connection between popular pain relievers, bladder cancer

Duration of ibuprofen use may be related to a reduced risk, especially in those with certain genetic marker

2012-11-07

(Press-News.org) (Lebanon, NH, 11/5/2012) — Dartmouth researchers have found that duration of ibuprofen use was associated with a reduced risk of bladder cancer in patients in northern New England, which has a high mortality rate of this disease. In a 2012 collaborative project with the National Cancer Institute, Margaret Karagas, PhD, co-director, Cancer Epidemiology & Chemoprevention program at Norris Cotton Cancer Center, and Professor of Community and Family Medicine at the Geisel School of Medicine at Dartmouth, and Richard Waddell, D.Sc, Research Assistant Professor of Medicine at the Geisel School of Medicine, looked for connections between ibuprofen use and bladder cancer.

Bladder cancer and ibuprofen use

Karagas did an earlier study on the relationship between bladder cancer and nonsteroidal anti-inflammatory drugs (NSAIDs) usage in New Hampshire. The new study included patients in Vermont and Maine. Researchers enrolled 1,171 participants newly diagnosed with bladder cancer and 1,418 participants who did not have bladder cancer. Karagas also added a genetic component looking at thirty-nine genes related to NSAID metabolism and studied a new class of NSAIDs known as selective cyclooxygenase (COX-2) inhibitors, such as celecoxib (Celebrex). Their results were published in the International Journal of Cancer (June 2012).

Those with specific genetic traits appear to have reduced risk

The findings in the recent study suggest that "regular use of nonaspirin nonselective NSAIDs, particularly ibuprofen, may reduce bladder cancer risk, especially among regular users for 10 years or more." However, the study also notes that observed reduction in risk was specific to individuals carrying a specific allele (or variant of a gene) related to NSAID metabolism.

Findings suggest further study needed for newer prescription pain reliever

For Karagas one of the novel findings was a trend of an increased risk of bladder cancer for those using selective COX-2 inhibitors, especially celocoxib (Celebrex). Karagas warns against leaping to any conclusions, noting, "further investigation is needed."

Karagas also stresses that this study "does not make any recommendations. It does not, in any way, suggest that patients begin taking ibuprofen as a prophylactic measure against bladder cancer, nor should patients go off any medicine prescribed by their doctor."

###This research study was funded by the National Institutes of Health Grant number: N02-CP-01037

About Norris Cotton Cancer Center at Dartmouth-Hitchcock Norris Cotton Cancer Center combines advanced cancer research at Dartmouth College and the Geisel School of Medicine at Dartmouth with patient-centered cancer care provided at Dartmouth-Hitchcock Medical Center, at Dartmouth-Hitchcock regional locations in Manchester, Nashua, and Keene, NH, and St. Johnsbury, VT, and at 12 partner hospitals throughout New Hampshire and Vermont. It is one of 41 centers nationwide to earn the National Cancer Institute's "Comprehensive Cancer Center" designation. Learn more about Norris Cotton Cancer Center research, programs, and clinical trials online at cancer.dartmouth.edu.

ELSE PRESS RELEASES FROM THIS DATE:

New drug target found for cystic fibrosis lung disease

2012-11-07

Vancouver researchers have discovered the cellular pathway that causes lung-damaging inflammation in cystic fibrosis (CF), and that reducing the pathway's activity also decreases inflammation. The finding offers a potential new drug target for treating CF lung disease, which is a major cause of illness and death for people with CF. "Developing new drugs that target lung inflammation would be a big step forward," says Dr. Stuart Turvey, who led the research. Dr. Turvey is the director of clinical research and senior clinician scientist at the Child & Family Research Institute ...

How butterfly wings can inspire new high-tech surfaces

2012-11-07

COLUMBUS, Ohio – A South American butterfly flapped its wings, and caused a flurry of nanotechnology research to happen in Ohio. Researchers here have taken a new look at butterfly wings and rice leaves, and learned things about their microscopic texture that could improve a variety of products. For example, the researchers were able to clean up to 85 percent of dust off a coated plastic surface that mimicked the texture of a butterfly wing, compared to only 70 percent off a flat surface. In a recent issue of the journal Soft Matter, the Ohio State University engineers ...

DNA sequencing of infants and children with anatomical defects of unknown causes

2012-11-07

A presentation at the American Society of Human Genetics 2012 meeting updated genetics experts about a one-year-old research initiative that brought together researchers, clinicians and policy experts to tackle the challenges of incorporating new genomic technologies into clinical care of newborns, infants and children with anatomical defects whose causes are unknown. Among the challenges is interpreting how variations in patients' DNA cause or contribute to their medical problems, said Duke University Assistant Professor of Pediatrics Erica E. Davis, Ph.D., who presented ...

Humans, chimpanzees and monkeys share DNA but not gene regulatory mechanisms

2012-11-07

Humans share over 90% of their DNA with their primate cousins. The expression or activity patterns of genes differ across species in ways that help explain each species' distinct biology and behavior. DNA factors that contribute to the differences were described on Nov. 6 at the American Society of Human Genetics 2012 meeting in a presentation by Yoav Gilad, Ph.D., associate professor of human genetics at the University of Chicago. Dr. Gilad reported that up to 40% of the differences in the expression or activity patterns of genes between humans, chimpanzees and rhesus ...

New method helps link genomic variation to protein production

2012-11-07

Scientists have adopted a novel laboratory approach for determining the effect of genetic variation on the efficiency of the biological process that translates a gene's DNA sequence into a protein, such as hemoglobin, according to a presentation, Nov. 6, at the American Society of Human Genetics 2012 meeting in San Francisco. In the 0.1% of the DNA that differs between any two individuals, scientists search for the biological mechanisms underlying human genetic differences, including disease susceptibility. "How exactly these slight changes in the DNA affect the biology ...

Strong tobacco control policies in Brazil credited for more than 400,000 lives saved

2012-11-07

WASHINGTON – High cigarette prices, smoke-free air laws, marketing restrictions and other measures, all part of Brazil's strong tobacco control policies, are credited for a 50 percent reduction in smoking prevalence between 1989 and 2010. The reduction contributed to an estimated 420,000 lives saved during that time period. Those are the findings of a new study published today in PLOS Medicine by a team of researchers from Georgetown Lombardi Comprehensive Cancer Center and the Brazilian National Cancer Institute. Adding to the dramatic conclusion of the study, which ...

Regular physical activity increases life expectancy even if overweight

2012-11-07

People who do regular physical activity, such as brisk walking, live longer than those who don't do any leisure time exercise, even when overweight, reports a study by international researchers published in this week's PLOS Medicine. These findings are important because, according to the authors (led by Steven Moore from the National Cancer Institute in Bethesda, USA): "This finding may help convince currently inactive persons that a modest physical activity program is ''worth it'' for health benefits, even if it may not result in weight control." The researchers from ...

Anti-tobacco policies responsible for Brazil's big success in reducing smoking rates

2012-11-07

Smoking rates in Brazil have dropped by half over the past two decades thanks to strict tobacco control policies, according to a study by US and Brazilian researchers published in this week's PLOS Medicine. Using a modeling simulation study called Brazil SimSmoke, the authors from authors from Lombardi Comprehensive Cancer Center of Georgetown University in Washington DC and the Brazilian National Cancer Institute in Rio de Janeiro, calculated that 46% of the reduction in smoking rates between 1989 and 2010 (34.8% of Brazilian adults smoked in 1989 compared to 18.5% in ...

China health system reform needs more accountability

2012-11-07

In this week's PLOS Medicine, David Hipgrave from the University of Melbourne, Australia and colleagues discuss health system reform in China and argue that parallel reforms in governance, financing, and accountability are also needed to ensure health equity. ### Funding: No specific funding was received to write this article. Competing Interests: The authors have declared that no competing interests exist. The opinions expressed in this paper reflect the perspectives of the authors alone, and may not be inferred to represent the position of their parent institutions. Citation: ...

Small change in defibrillator therapy leads to huge benefits for heart patients

2012-11-07

A new study shows that defibrillators – devices designed to detect and correct dangerous heart rhythms – can help people with heart disease live longer, and with a much better quality of life, than they do now. A small, very simple change in the way physicians set or programmed the device led to a dramatic 80 to 90 percent reduction in inappropriate therapies – potentially painful and anxiety-provoking shocks delivered for rhythms that aren't dangerous or life threatening. And, to the authors' surprise, the new programming also significantly increased survival, lowering ...

Researchers explore connection between popular pain relievers, bladder cancer

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: